HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shengyu Zhou Selected Research

Hemoglobins (Hemoglobin)

1/2021Clinical Features for Severely and Critically Ill Patients with COVID-19 in Shandong: A Retrospective Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shengyu Zhou Research Topics

Disease

12Lymphoma (Lymphomas)
07/2022 - 01/2009
10Neoplasms (Cancer)
07/2022 - 01/2007
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 11/2018
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2022 - 02/2015
4Adenocarcinoma of Lung
10/2021 - 08/2008
3Disease Progression
04/2022 - 01/2020
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2020 - 02/2015
3Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2017 - 01/2009
2T-Cell Lymphoma (Lymphoma, T Cell)
07/2022 - 11/2019
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
07/2022 - 02/2015
2Infections
01/2022 - 03/2021
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2021 - 01/2021
2Hypertension (High Blood Pressure)
01/2021 - 01/2020
2Nasopharyngeal Carcinoma
01/2020 - 08/2015
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/2017 - 10/2016
2Neutropenia
02/2017 - 01/2016
2B-Cell Lymphoma (Lymphoma, B Cell)
09/2015 - 02/2015
1Stomach Neoplasms (Stomach Cancer)
07/2022
1COVID-19
01/2022
1Reinfection
03/2021
1Bacterial Infections (Bacterial Infection)
01/2021
1Coronary Disease (Coronary Heart Disease)
01/2021
1Drug-Related Side Effects and Adverse Reactions
12/2020
1Renal Cell Carcinoma (Grawitz Tumor)
12/2020
1Neoplasm Metastasis (Metastasis)
12/2020
1Brain Diseases (Brain Disorder)
01/2020
1Proteinuria
01/2020
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020
1Alveolar Soft Part Sarcoma
01/2020
1Pneumonia (Pneumonitis)
01/2020
1Extranodal NK-T-Cell Lymphoma
11/2019
1Brain Neoplasms (Brain Tumor)
06/2019
1Lung Neoplasms (Lung Cancer)
01/2018
1Thrombocytopenia (Thrombopenia)
02/2017
1Anemia
02/2017

Drug/Important Bio-Agent (IBA)

7Rituximab (Mabthera)FDA Link
05/2022 - 09/2015
5GemcitabineFDA Link
11/2019 - 02/2014
4PlatinumIBA
12/2020 - 08/2015
4Cisplatin (Platino)FDA LinkGeneric
11/2019 - 10/2016
4Guanosine Diphosphate (GDP)IBA
11/2019 - 10/2016
4Dexamethasone (Maxidex)FDA LinkGeneric
11/2019 - 07/2015
3Anaplastic Lymphoma KinaseIBA
07/2022 - 02/2015
3Biomarkers (Surrogate Marker)IBA
07/2022 - 01/2020
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2017 - 08/2014
2Immunoglobulin G (IgG)IBA
07/2022 - 01/2020
2AntibodiesIBA
07/2022 - 03/2021
2EnzymesIBA
07/2022 - 01/2020
2AutoantibodiesIBA
07/2022 - 01/2020
2AnthracyclinesIBA
04/2022 - 11/2019
2Tyrosine Kinase InhibitorsIBA
10/2021 - 06/2019
2RNA (Ribonucleic Acid)IBA
03/2021 - 08/2015
2Pemetrexed (MTA)FDA Link
10/2019 - 11/2018
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2017 - 09/2015
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2015 - 08/2014
2IfosfamideFDA LinkGeneric
08/2015 - 07/2015
1LigandsIBA
07/2022
1MicronutrientsIBA
01/2022
1Hydroxyl RadicalIBA
11/2021
11-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2021
1hydroxide ionIBA
11/2021
1ErbB Receptors (EGF Receptor)IBA
10/2021
1anlotinibIBA
10/2021
1pembrolizumabIBA
10/2021
1osimertinibIBA
10/2021
1Thrombopoietin (c-mpl Ligand)IBA
09/2021
1ProcalcitoninIBA
01/2021
1Hemoglobins (Hemoglobin)IBA
01/2021
1fibrin fragment D (D-dimer)IBA
01/2021
1Paclitaxel (Taxol)FDA LinkGeneric
12/2020
1Carboplatin (JM8)FDA LinkGeneric
12/2020
1Bevacizumab (Avastin)FDA Link
12/2020
1Monoclonal AntibodiesIBA
12/2020
1Sunitinib (Sutent)FDA Link
12/2020
1Programmed Cell Death 1 ReceptorIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1apatinibIBA
01/2020
1Carnitine (L-Carnitine)FDA LinkGeneric
01/2020
1ibrutinibIBA
01/2020
1Nucleic AcidsIBA
01/2020
1AntioxidantsIBA
01/2020
1nimotuzumabIBA
01/2020
1Circulating Tumor DNAIBA
10/2019
1icotinibIBA
06/2019
1EndostatinsIBA
11/2018
1endostar proteinIBA
11/2018
1Therapeutic UsesIBA
01/2018
1Growth Factor ReceptorsIBA
01/2018
1Etoposide (VP 16)FDA LinkGeneric
10/2017
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2017
1Carmustine (FIVB)FDA Link
10/2017
1Melphalan (Alkeran)FDA LinkGeneric
10/2017
1Filgrastim (Neupogen)FDA Link
01/2016

Therapy/Procedure

23Drug Therapy (Chemotherapy)
04/2022 - 01/2007
7Therapeutics
07/2022 - 10/2014
3Radiotherapy
11/2019 - 01/2009
2Stem Cell Transplantation
04/2022 - 01/2009
2Hematopoietic Stem Cell Transplantation
10/2017 - 02/2015
1Autologous Transplantation
09/2021
1Nephrectomy
12/2020
1VAP-cyclo protocol
10/2015